doxylamine succinate and pyridoxine hydrochloride
doxylamine succinate and pyridoxine hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including DICLEGIS, BONJESTA. Available dosage forms: tablet, delayed release, tablet, extended release.
Drug details
- Generic Name
- doxylamine succinate and pyridoxine hydrochloride
- Brand Names
- DICLEGIS, BONJESTA
- Application Number
- NDA021876
- Sponsor
- Duchesnay USA, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, DELAYED RELEASE, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. Limitations of Use Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets havenot been studied in women with hyperemesis gravidarum. Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are a fixed dose combination drug product of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a Vitamin B 6 analog, indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. ( 1 )